FDA approves 1st mRNA flu shot, from Moderna
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"FDA approves 1st mRNA flu shot, from Moderna" is generating significant coverage in the Health category, with 1 articles from 1 distinct sources tracked by PULSE so far.
Outlets currently covering the story include NBC News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 1h ago.
Quick answers
Why is "FDA approves 1st mRNA flu shot, from Moderna" trending?
Because 1 independent news sources published 1 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (2)
- FDA approves 1st mRNA flu shot, from Moderna NBC News · 3h ago
- US FDA approves first mRNA flu shot from Moderna Reuters · 3h ago
Topics
Related trends
F.D.A. Approves Moderna’s mRNA Flu Vaccine
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
As FDA makes Lipfendra poster child of CNPV pilot, Merck charts long-term path for first PCSK9 pill
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New blood test to detect colon cancer clears FDA approval
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Nicotine pouches can be marketed as 'lower risk' than cigarettes. Is that dangerous?
Federal authorization of new flavored nicotine pouches sparks debate over marketing them as lower risk than cigarettes.
Pancreatic cancer drug now available in Cleveland offers new hope
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.